期刊文献+

胰岛素聚氰基丙烯酸正丁酯纳米粒在油介质中的稳定性及其对糖尿病大鼠的降血糖作用(英文) 被引量:5

The stability of insulin-loaded polybutylcyanoacrylate nanoparticles in an oily medium and the hypoglycemic effect in diabetic rats
下载PDF
导出
摘要 目的 通过对胰岛素聚氰基丙烯酸正丁酯纳米粒(IPN)在油介质(含有 0 .5%吐温 20和 5%维生素E的豆油)中的稳定性及其口服后对链脲霉素引起的糖尿病大鼠降血糖作用的研究,希望得到一种稳定而有效的胰岛素纳米粒口服制剂。方法 依据IPN中的胰岛素含量,IPN的平均粒径和粒子跨度,及其体外释药来评估其稳定性。将IPN分散在含有 0 .5% 吐温 20,pH2 0的水溶液中作为对照。结果 研究表明,不论样品是在(25±2)℃条件下避光放置 1年,还是在体外与 3种消化道酶 37℃酶解 30min,油介质中的IPN都比水介质中IPN稳定性好。依据单剂量po给药后,在 0-144h血糖降低的百分数与时间曲线上面积(AAC)可知,poIPN的油溶液(50u·kg-1 )相对于sc胰岛素(2u·kg-1 )的生物利用度为 22 .4%,明显高于poIPN水溶液的相对生物利用度(15. 5% )。结论 分散在油介质中的IPN具有较好的稳定性和相对较高的生物利用度,因此,含有 0 .5%吐温 20和 5%维生素E的豆油有望成为口服胰岛素聚氰基丙烯酸正丁酯纳米粒的有效而稳定的分散介质。 Aim To study the stability of insulin-loaded polybutylcyanoacrylate nanoparticles (IPN) in an oily medium (soybean oil containing 0.5% (v/v) Tween-20 and 5% (v/v) Vitamin E) along with the hypoglycemic effect following their oral administration to streptozotocin (STZ) induced diabetic rats. Methods The stability of IPN in the process was appraised by measurement of the amount of undegraded insulin associated to nanoparticles, the average size and the span of IPN, as well as the release of insulin from IPN. IPN in an aqueous medium (containing 0.5% (v/v) Tween-20) at pH 2.0 was also investigated as control. Results The study showed that IPN in the oily medium was more stable than that in the aqueous medium over one year of storage in the dark at (25±2) ℃ and the in vitro stability of IPN in the oily medium against degradation by proteolytic enzymes was much better than that in the aqueous medium. The apparent bioavailability of an oral administration of IPN (50 u·kg-1) in the oily medium versus an (sc) injection of insulin (2 u·kg-1) was 22.4%, much higher than that of IPN in the aqueous medium (15.5%), based on decreased areas above curve (AAC) determination for the blood glucose depression from time zero to 144 h of a single oral administration of IPN to STZ-diabetic rats. Conclusion IPN in soybean oil containing Tween-20 (0.5% v/v) and Vitamin E (5% v/v) could be considered as an effective and stable delivery system for oral insulin.
出处 《药学学报》 CAS CSCD 北大核心 2005年第1期57-64,共8页 Acta Pharmaceutica Sinica
基金 SupportedbytheDoctorateFoundationofXi'anJiaotongUniversity(DFXJTU2001 2).
关键词 口服给药 胰岛素 聚氰基丙烯酸正丁酯 纳米粒 稳定性 降血糖作用 oral administration insulin polybutylcyanoacrylate nanoparticles stability hypoglycemic effect
  • 相关文献

参考文献14

  • 1段明星,乐志操,马红,郑昌学.氰基丙烯酸酯包裹胰岛素纳米颗粒的结构[J].中国药学杂志,1999,34(1):23-26. 被引量:41
  • 2YangC HuL XuL etal.Hypoglycemiceffectofinsulin-nanoparticlesondiabeticrats.JFourthMilMedUniv(第四军医大学学报),2001,22(6):696-700.
  • 3YinZ LuB.Studyonsustainedreleaseinsulinnanoparticlesforinjection.ChinPharmJ(中国药学杂志),2000,31(3):349-352.
  • 4Zhang Q, Shen Z, Nagai T. Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats [ J ]. Int J Pharm, 2001,218 ( 1 ) :75 - 80.
  • 5Sommerfeld P, Schroeder U, Sabel BA. Long-term stability of PBCA nanoparticle suspensions suggests clinical usefulness [ J ]. Int J Pharm, 1997,155 (2):201 - 207.
  • 6Sommerfeld P, Schroeder U, Sabel BA. Sterilization of unloaded polybutylcyanoacrylate nanoparticles [ J]. Int J Pharm, 1998,164(1) :113 -118.
  • 7Scherer D, Kreuter J, Robinson JR. Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles [J]. Int J Pharm, 1994,101 (2): 165 -168.
  • 8Lowe PJ, Temple GS. Calcitonin and insulin in isobutylcyanoacrylate nanoparticles: protection against proteases and effect on intestinal absorption in rats [ J ]. J Pharm Pharmacol, 1994,46 (5) :547 - 552.
  • 9Michel C, Aprahamian M, Defontaine L, et al. The effect of site of administration in the gastrointestinal tract on the absorption of insulin from nanoparticles in diabetic rats [J]. J Pharm Pharmacol, 1991,43(1) :1 -5.
  • 10Damg C, Vranckx H, Balschmidt P, et al. Poly (alkylcyanoacrylate) nanospheres for oral administration of insulin [ J ]. J Pharm Sci, 1997,86 ( 12 ): 1403 - 1409.

二级参考文献1

  • 1Duan M X,CRSCPA joint wordshop Recent advances drug delivery science Technology,1997年

共引文献40

同被引文献130

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部